Powered by Hamilton Lane. Learn more about the private markets.

AeroSafe is a premier leader in the pharmaceutical cold chain industry, enabling its biopharma partners to safely deliver their life-saving therapies to healthcare providers and patients with its end-to-end sustainable solutions.

With a unique business model built on reusable shippers and unmatched reverse logistics services, AeroSafe provides biopharma partners with hassle-free sustainable solutions to safely deliver their temperature-sensitive products, significantly reducing the amount of landfill waste. 

INDUSTRY

Business Services

Sustainable Processes

IMPACT SECTOR

AeroSafe's Impact

  • In response to the COVID-19 pandemic, AeroSafe was selected to help deliver COVID-19 vaccines globally, owing to its outstanding cold chain capability to keep packages at -70˚C for several weeks   
  • 98%+ return rate on its durable and highly customizable shippers sustains the continued reuse of each shipper, reducing the impact on landfills 
  • AeroSafe has been proven to reduce biopharma product loss from temperature excursions by 20%, thereby ensuring product quality while delivering customer satisfaction  


Alignment of Social and Business Mission 
  • AeroSafe’s mission is to improve patient lives by ensuring the safe, sustainable delivery and effective use of biopharma therapeutics. The company is committed to tackling the most pressing challenges in the global pharma supply chain industry by driving our growth through innovation and customer dedication.


Impact metrics tracked1 

1As of June 2022. Metrics calculated and provided directly by the general partner or underlying company. 

tons of CO2 reduced
(24,000 metrics tons)

26,500

789K  

reused shipments, on track to exceed 1M in 2022

Shipments of COVID-19 vaccine, containing up to 670K doses

250K

Reduction in landfill waste 

13K tons

Data provided directly by the general partner or underlying company.

Powered by Hamilton Lane.
Learn more about the private markets.

AeroSafe

Impact metrics tracked1 

tons of CO2 reduced
(24,000 metrics tons)

26,500

789K  

reused shipments, on track to exceed 1M in 2022

Reduction in landfill waste 

13K tons

Data provided directly by the general partner or underlying company.

1As of June 2022. Metrics calculated and provided directly by the general partner or underlying company. 

Shipments of COVID-19 vaccine, containing up to 670K doses

250K

  • AeroSafe’s mission is to improve patient lives by ensuring the safe, sustainable delivery and effective use of biopharma therapeutics. The company is committed to tackling the most pressing challenges in the global pharma supply chain industry by driving our growth through innovation and customer dedication.


Alignment of Social and Business Mission 
  • In response to the COVID-19 pandemic, AeroSafe was selected to help deliver COVID-19 vaccines globally, owing to its outstanding cold chain capability to keep packages at -70˚C for several weeks   
  • 98%+ return rate on its durable and highly customizable shippers sustains the continued reuse of each shipper, reducing the impact on landfills 
  • AeroSafe has been proven to reduce biopharma product loss from temperature excursions by 20%, thereby ensuring product quality while delivering customer satisfaction  


AeroSafe's Impact

Sustainable Processes

IMPACT SECTOR

INDUSTRY

Business Services

With a unique business model built on reusable shippers and unmatched reverse logistics services, AeroSafe provides biopharma partners with hassle-free sustainable solutions to safely deliver their temperature-sensitive products, significantly reducing the amount of landfill waste. 

AeroSafe is a premier leader in the pharmaceutical cold chain industry, enabling its biopharma partners to safely deliver their life-saving therapies to healthcare providers and patients with its end-to-end sustainable solutions.